1. Home
  2. RGLS vs SLNG Comparison

RGLS vs SLNG Comparison

Compare RGLS & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • SLNG
  • Stock Information
  • Founded
  • RGLS 2007
  • SLNG 2013
  • Country
  • RGLS United States
  • SLNG United States
  • Employees
  • RGLS N/A
  • SLNG N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • RGLS Health Care
  • SLNG Utilities
  • Exchange
  • RGLS Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • RGLS 102.1M
  • SLNG 85.4M
  • IPO Year
  • RGLS 2012
  • SLNG N/A
  • Fundamental
  • Price
  • RGLS $1.55
  • SLNG $6.10
  • Analyst Decision
  • RGLS Strong Buy
  • SLNG
  • Analyst Count
  • RGLS 6
  • SLNG 0
  • Target Price
  • RGLS $10.33
  • SLNG N/A
  • AVG Volume (30 Days)
  • RGLS 268.2K
  • SLNG 15.2K
  • Earning Date
  • RGLS 11-07-2024
  • SLNG 11-06-2024
  • Dividend Yield
  • RGLS N/A
  • SLNG N/A
  • EPS Growth
  • RGLS N/A
  • SLNG N/A
  • EPS
  • RGLS N/A
  • SLNG 0.21
  • Revenue
  • RGLS N/A
  • SLNG $74,044,000.00
  • Revenue This Year
  • RGLS N/A
  • SLNG N/A
  • Revenue Next Year
  • RGLS N/A
  • SLNG N/A
  • P/E Ratio
  • RGLS N/A
  • SLNG $30.85
  • Revenue Growth
  • RGLS N/A
  • SLNG N/A
  • 52 Week Low
  • RGLS $1.08
  • SLNG $3.77
  • 52 Week High
  • RGLS $3.79
  • SLNG $7.15
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 49.06
  • SLNG 61.07
  • Support Level
  • RGLS $1.49
  • SLNG $5.26
  • Resistance Level
  • RGLS $1.62
  • SLNG $5.92
  • Average True Range (ATR)
  • RGLS 0.11
  • SLNG 0.49
  • MACD
  • RGLS -0.00
  • SLNG 0.04
  • Stochastic Oscillator
  • RGLS 37.50
  • SLNG 46.15

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: